Skip to main content
. 2021 Mar 8;11:5385. doi: 10.1038/s41598-021-84885-4

Figure 1.

Figure 1

Kaplan–Meier curves showing central venous port (CVP) availability in (a) all patients, (b) patients with malignant or benign disease, and (c) patients with Orphis CV Kit Neo or Bard X-Port isp. Kaplan–Meier curves showing CVP availability in (d) patients with malignancies or (e) patients implanted for chemotherapy. Significance determined by the log-rank test is shown.